Skip to content
healthcare.dev

Industriox 6011

NDC 63083-6011, Industriox, liquid, from Professional Complementary Health Formulas.

Product NDC
63083-6011
Status
Listed
Labeler
Professional Complementary Health Formulas
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63083-6011 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BERBERIS VULGARIS ROOT BARK3 [hp_X]/59mL
  • TARAXACUM OFFICINALE3 [hp_X]/59mL
  • AMMONIUM CATION6 [hp_X]/59mL
  • CAMPHOR (NATURAL)6 [hp_X]/59mL
  • STRYCHNOS NUX-VOMICA SEED6 [hp_X]/59mL
  • SULFURIC ACID6 [hp_X]/59mL
  • OYSTER SHELL CALCIUM CARBONATE, CRUDE12 [hp_X]/59mL
  • LACHESIS MUTA VENOM12 [hp_X]/59mL
  • LEAD12 [hp_X]/59mL
  • ACETONE30 [hp_X]/59mL
  • ACRYLIC ACID30 [hp_X]/59mL
  • BENZENE30 [hp_X]/59mL
  • CARBON TETRACHLORIDE30 [hp_X]/59mL
  • CHLOROFORM30 [hp_X]/59mL
  • METHYL ETHYL KETONE30 [hp_X]/59mL
  • FORMALDEHYDE SOLUTION30 [hp_X]/59mL
  • TERT-BUTYL METHYL ETHER30 [hp_X]/59mL
  • NAPHTHALENE30 [hp_X]/59mL
  • LIQUID PETROLEUM30 [hp_X]/59mL
  • TRICHLOROETHYLENE30 [hp_X]/59mL

Pharmacologic classes

Allergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Plant Allergenic Extract [EPC]; Plant Proteins [CS]; Seed Storage Proteins [CS]

Package NDCNDC-11Package
63083-6011-26308360110259 mL in 1 BOTTLE, DROPPER (63083-6011-2)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 63083-6011 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63083-6011 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63083-6011. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.